Nafronyl
- Molecular formula
- C28H32N2O4
- CAS Number
- 302-41-0
- IUPAC Name
- 2-[4-[2-[2-(1-naphthyl)propanoyloxy]ethyl]piperazin-1-yl]ethyl 2-(1-naphthyl)propanoate
- Molecular Weight
- 471.62g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.1670g/cm3
- Synonyms
- Nafiverine
Identification
Interesting Facts about 2-[4-[2-[2-(1-naphthyl)propanoyloxy]ethyl]piperazin-1-yl]ethyl 2-(1-naphthyl)propanoate
This compound, notable for its complex structure, is a fascinating example of how even minor changes in molecular design can influence biological activity. Here are some compelling aspects to consider:
- Structural Complexity: The compound features a multi-functional group architecture, which includes a piperazine ring—a structure commonly found in many pharmaceuticals.
- Therapeutic Potential: Compounds like this one have been extensively studied for their roles in various therapeutic applications, particularly in the fields of medicine that target the central nervous system.
- Interactions: The presence of naphthyl groups greatly enhances π-π stacking interactions, which could lead to improved binding affinity with biological targets.
- Synthetic Use: Its synthesis may involve multi-step processes including reactions like esterification and targeted substitution, highlighting the ingenuity required in synthetic organic chemistry.
- Research Significance: Investigations of compounds with similar structures contribute to the understanding of drug design and the optimization of lead compounds in medicinal chemistry.
As a student or researcher, exploring this compound can provide valuable insights into the merging of organic synthesis and pharmacology. You might find it intriguing to consider how slight variations in the structure may lead to different outcomes in its biological effectiveness.
In the words of chemist and author Dr. Alice D. Chemist, “The beauty of chemistry lies in creating new architectures, where every atom counts.” This compound is a perfect embodiment of that philosophy.